Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Creating a retirement plan for those over 50? Discover essential elements to include for a successful retirement strategy.
26,197 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
At the dawn of 2026, rental demand isn’t following the usual big-city script. Cities like Cincinnati, Atlanta, and Mi...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
As e.l.f. Beauty moves into 2026, investors want clarity on growth drivers and risk. This guide breaks down the Q4 ou...
This article breaks down APi Group's Q1 2026 earnings call, translating the numbers into actionable takeaways for inv...
Two giants. One decision. This pipeline stock face-off: enbridge breaks down which energy infrastructure stock fits a...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
A new Morgan Stanley note argues Rocket Lab’s shift into satellite data and services could unlock substantial upside,...
A fashion-forward label bends into audio, turning a five-day NYC pop-up into a live case study in branding, spending,...
As energy demand grows—from data centers to next-gen reactors—centrus energy stock potential captures the imagination...
Investors are closely watching rivian’s stock ahead major launch as the company advances the R2 SUV, a lower-priced m...